Cardiorenal Research Laboratory and Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Circulation. 2013 Sep 3;128(10):1085-93. doi: 10.1161/CIRCULATIONAHA.113.001475. Epub 2013 Aug 1.
In patients with heart failure and preserved ejection fraction (HFpEF), atrial fibrillation (AF) may predate, concur with, or develop after HFpEF diagnosis. We sought to define the temporal relationship between AF and HFpEF, to identify factors associated with AF, and to determine the prognostic impact of prevalent and incident AF in HFpEF.
From 1983 to 2010, 939 Olmsted County, Minnesota, residents (age, 77±12 years; 61% female) newly diagnosed with HFpEF (EF ≥0.50) were evaluated. Baseline rhythm classification included prior AF (>3 months before HFpEF diagnosis), concurrent AF (±3 months), or sinus rhythm. Incident AF (>3 months after HFpEF diagnosis) and all-cause mortality were ascertained through February 2012. Prior AF (29%) and concurrent AF (23%) were associated with older age, higher brain-type natriuretic peptide, and larger left atrial volume index at HFpEF diagnosis compared with sinus rhythm. Of HFpEF patients in sinus rhythm at diagnosis, 32% developed AF over a median follow-up of 3.7 years (interquartile range, 1.5-6.7 years; 69 events per 1000 person-years). Age and diastolic dysfunction were positively and statin use was inversely associated with incident AF. With no AF used as the referent, prior or concurrent AF (combined hazard ratio, 1.3; 95% confidence interval, 1.0-1.6; P=0.03) and incident AF, modeled as a time-dependent covariate (hazard ratio, 2.1; 95% confidence interval, 1.4-3.0; P<0.001), were independently associated with death after adjustment for pertinent covariates.
AF occurs in two thirds of HFpEF patients at some point in the natural history and confers a poor prognosis. Further study is required to determine whether intervention for AF may improve outcomes or if statin use can prevent AF in HFpEF.
在射血分数保留的心力衰竭(HFpEF)患者中,心房颤动(AF)可能先于、同时或后于 HFpEF 诊断发生。我们旨在确定 AF 与 HFpEF 之间的时间关系,确定与 AF 相关的因素,并确定 HFpEF 中持续性和新发 AF 的预后影响。
1983 年至 2010 年,明尼苏达州奥姆斯特德县 939 名新诊断为 HFpEF(EF≥0.50)的居民(年龄 77±12 岁;61%为女性)接受了评估。基线节律分类包括先前的 AF(HFpEF 诊断前>3 个月)、同期 AF(±3 个月)或窦性节律。通过 2012 年 2 月确定新发 AF(HFpEF 诊断后>3 个月)和全因死亡率。与窦性节律相比,先前的 AF(29%)和同期 AF(23%)与年龄较大、脑利钠肽水平较高和左心房容积指数较大相关。在 HFpEF 诊断时处于窦性节律的患者中,32%在中位随访 3.7 年后(四分位距,1.5-6.7 年;每 1000 人年 69 例)发生 AF。年龄和舒张功能障碍与新发 AF 呈正相关,而他汀类药物的使用与新发 AF 呈负相关。以无 AF 为参照,先前或同期 AF(联合危险比,1.3;95%置信区间,1.0-1.6;P=0.03)和作为时变协变量建模的新发 AF(危险比,2.1;95%置信区间,1.4-3.0;P<0.001)在调整相关协变量后,与死亡独立相关。
在 HFpEF 患者的自然病史中,有三分之二的患者在某个时间点发生 AF,预后不良。需要进一步研究确定 AF 的干预是否可以改善结局,或者他汀类药物的使用是否可以预防 HFpEF 中的 AF。